In the News this Week: New Methods for Cancer Detection, Point-of-Care on the Football Pitch, and NGS Sample Prep

Read our top stories in the news this week:

New Device Sniffs Out Deadly Lung Cancer
Lung cancer causes more deaths in the U.S. than the next three most common cancers combined (colon, breast, and pancreatic). The reason for the striking mortality rate is simple: poor detection. Now, a new breathalyzer test developed by a team of Israeli, American, and British cancer researchers may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.

Scoring Goals with Point-of-Care Technology
This article highlights how interesting parallels can be made between the use of point-of-care technology on the football pitch and its use in clinical settings.

A Better Imager for Identifying Tumors: Smaller, Cheaper Two-Mode Imaging System Could Help Surgeons See and Remove Cancer
Before they excise a tumor, surgeons need to determine exactly where the cancerous cells lie. Now, research published last week in The Optical Society's (OSA) journal Optics Letters details a new technique that could give surgeons cheaper and more lightweight tools, such as goggles or hand-held devices, to identify tumors in real time in the operating room.

AMSBIO Announces Tool for Consistent and Efficient Purification of NGS Library Reactions
AMSBIO has announced a new magnetic bead based tool that offers an efficient solution for DNA clean-up and size selection in Next Generation Sequencing (NGS) applications.

New Mass Spectrometer for Life-Science Research, Clinical Research, Biopharma and Applied Markets
The new impact II system is the latest innovation in Bruker’s unique UHR-QTOF (ultra-high resolution Qq-time-of-flight) mass spectrometry product line, now with industry-leading >50,000 Full-Sensitivity Resolution (FSR). It offers further enhanced analytical performance levels for all applications where trace analysis from complex, high-background matrices is a challenge – such as proteomics, biomarker research, identification of impurities, or residue screening.